Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection.

TLDR: Different modalities of Mtb-mediated host cell deaths, the molecular mechanisms underpinning the host cell death during Mtb infection, and its potential implications for host immunity are summarized.

Abstract: Mycobacterium tuberculosis (Mtb) is the pathogen that causes tuberculosis (TB), a leading infectious disease of humans worldwide. One of the main histopathological hallmarks of TB is the formation of granulomas comprised of elaborately organized aggregates of immune cells containing the pathogen. Dissemination of Mtb from infected cells in the granulomas due to host and mycobacterial factors induces multiple cell death modalities in infected cells. Based on molecular mechanism, morphological characteristics, and signal dependency, there are two main categories of cell death: programmed and non-programmed. Programmed cell death (PCD), such as apoptosis and autophagy, is associated with a protective response to Mtb by keeping the bacteria encased within dead macrophages that can be readily phagocytosed by arriving uninfected or neighboring cells. In contrast, non-PCD necrotic cell death favors the pathogen, resulting in the bacterial release into the extracellular environment. Multiple types of cell death in the PCD category, including pyroptosis, necroptosis, ferroptosis, ETosis, parthanatos, and PANoptosis, may be involved in Mtb infection. Since PCD pathways are essential for host immunity to Mtb, therapeutic compounds targeting cell death signaling pathways have been experimentally tested for TB treatment. This review summarizes different modalities of Mtb-mediated host cell deaths, the molecular mechanisms underpinning the host cell death during Mtb infection, and its potential implications for host immunity. Additionally, targeting host cell death pathways as potential therapeutic and preventive approaches against Mtb infection is also discussed.